Windlas Biotech was incorporated on February 19, 2001. The company is in the domestic pharmaceutical formulations contract development and manufacturing business. It manufactures both solid and liquid pharmaceutical dosage and provides specialized capabilities, including, high potency, controlled substances and low-solubility along with a comprehensive range of CDMO services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics, in compliance with current Good Manufacturing Practices with a focus on improved safety, efficacy and cost.